Apricus Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.01M Buy
19,714
+132
+0.7% +$30.8K 2.39% 7
2026
Q1
$4.79M Sell
19,582
-903
-4% -$210K 2.33% 5
2025
Q4
$4.24M Buy
20,485
+465
+2% +$92K 2.17% 10
2025
Q3
$3.71M Buy
20,020
+235
+1% +$40.3K 2% 14
2025
Q2
$3.02M Sell
19,785
-210
-1% -$32.3K 1.76% 20
2025
Q1
$3.32M Buy
19,995
+2,215
+12% +$347K 1.97% 19
2024
Q4
$2.57M Buy
17,780
+3,989
+29% +$618K 1.67% 24
2024
Q3
$2.23M Buy
13,791
+322
+2% +$51.3K 1.47% 35
2024
Q2
$1.97M Buy
13,469
+640
+5% +$95.2K 1.41% 34
2024
Q1
$2.03M Sell
12,829
-647
-5% -$103K 1.43% 34
2023
Q4
$2.11M Buy
13,476
+754
+6% +$116K 1.61% 29
2023
Q3
$2M Sell
12,722
-455
-3% -$75.1K 1.74% 26
2023
Q2
$2.1M Buy
13,177
+701
+6% +$113K 1.84% 24
2023
Q1
$1.93M Sell
12,476
-4,939
-28% -$798K 1.76% 26
2022
Q4
$3.08M Buy
17,415
+168
+1% +$29K 2.8% 8
2022
Q3
$2.82M Buy
17,247
+162
+0.9% +$27.4K 2.8% 10
2022
Q2
$3.03M Buy
17,085
+1,039
+6% +$185K 2.78% 7
2022
Q1
$2.95M Buy
16,046
+1,854
+13% +$315K 2.41% 13
2021
Q4
$2.43M Buy
+14,192
New +$2.32M 2.17% 16

Other funds holding JNJ

Apricus Wealth's JNJ Position: Q2 2026 in Review

Apricus Wealth increased its Johnson & Johnson (JNJ) stake by 0.67% in Q2 2026, buying an estimated $30.8K and bringing the position to 19,714 shares worth $5.01M. The position accounts for 2.39% of the portfolio, ranked #7.

Apricus Wealth first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 1,836 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Apricus Wealth held 19,714 shares of Johnson & Johnson worth $5.01M as of Q2 2026.
  • Apricus Wealth bought 132 Johnson & Johnson shares in Q2 2026, an estimated $30.8K.
  • Johnson & Johnson made up 2.39% of Apricus Wealth's portfolio in Q2 2026, its #7 holding.
  • Apricus Wealth first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 1,836 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Apricus Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.